Association Between Lipoprotein(a) and Long-term Outcomes after Percutaneous Coronary Intervention for Lesions with In-stent Restenosis

Percutaneous coronary intervention (PCI) with stent implantation is the most common therapeutic option for patients with obstructive coronary artery disease (CAD). The major drawback of this procedure is in-stent restenosis (ISR), due to biological, mechanical or other mechanisms. Despite the development of new-generation drug-eluting stents (DES), intervention of ISR consistently accounts for about 10% of overall PCI procedures,1 Management of ISR depends on underlying patient-, lesion-related mechanism and procedural-related risk factors for ISR, including diabetes mellitus, hypercholesterolemia, anatomic complexity, stent under-expansion, geographic miss or edge dissection, et al.

Source: Journal of Clinical Lipidology - May 18, 2023 Category: Lipidology Authors: Han Zhang, Yin Zhang, Tao Tian, Tianjie Wang, Jue Chen, Jinqing Yuan, Jie Qian, Fenghuan Hu, Kefei Dou, Shubin Qiao, Yongjian Wu, Changdong Guan, Bo Xu, Weixian Yang, Lei Song Tags: Original Research Source Type: research